Optic pathway glioma

Active Research Protocols

  1. 12-C-0058 – A Phase II Study of Everolimus (RAD001) for Children with Neurofibromatosis Type-1 and Chemotherapy-Refractory Radiographic Progressive Low-Grade Gliomas
  2. 12-C-0136 – A Phase II Randomized Trial of Lenalidomide (NSC # 703813, IND # 70116) in Pediatric Patients with Recurrent, Refractory or Progressive Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014